PEGGY V. PHILLIPS - Corporate Board Profile

DYNAVAX TECHNOLOGIES CORP

Filing Date	Source Excerpt
2012-04-25	Peggy V. Phillips 58 Director ... Our Board has three committees: an Audit Committee, a Compensation Committee and a Nominating and Governance Committee. The following table provides membership and meeting information for fiscal 2011 for each of the Board committees: Peggy V. Phillips X X * ... The following table shows for the fiscal year ended December 31, 2011 certain information with respect to the compensation of all non-employee directors of the Company: Peggy V. Phillips $52,000 $22,846 $74,846
2013-04-29	Peggy V. Phillips 59 Director ... The following table shows for the fiscal year ended December 31, 2012, certain information with respect to the compensation of all non-employee directors of the Company: Peggy V. Phillips Fees Earned or Paid in Cash $72,000 Options and Awards Granted $183,419 Total $255,419 ... The Compensation Committee is composed of three directors: Ms. Phillips (Chairperson) and Drs. Kisner and Cano. Our Nominating and Governance Committee is composed of two directors: Drs. Kisner (Chairperson) and Cano.
2014-04-28	Peggy V. Phillips 60 Director ... Our Board has three committees: an Audit Committee, a Compensation Committee and a Nominating and Governance Committee ... The following table shows for the fiscal year ended December 31, 2013, certain information with respect to the compensation of all non-employee directors of the Company: Peggy V. Phillips Fees Earned or Paid in Cash $63,000 Options and Awards Granted $44,625 Total $107,625
2015-04-21	Peggy V. Phillips 61 Director ... Ms. Phillips has been a member of our Board since August 2006. ... The following table shows for the fiscal year ended December 31, 2014, certain information with respect to the compensation of all non-employee directors of the Company: Peggy V. Phillips $62,500 fees earned or paid in cash, $22,901 options and awards, total $85,401.
2016-04-22	Peggy V. Phillips 62 Director ... Our Compensation Committee is composed of three directors: Ms. Phillips (Chairperson) and Drs. Kisner and Cano ... Our Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Governance Committee ... The following table shows for the fiscal year ended December 31, 2015, certain information with respect to the compensation of all non-employee directors of the Company: Peggy V. Phillips $62,500 Fees Earned or Paid in Cash, $294,558 Option Awards, $357,058 Total.
2017-04-21	Peggy V. Phillips 63 Director ... Our Compensation Committee is composed of three directors: Ms. Phillips (Chairperson) and Drs. Cano and Kisner ... The Audit Committee for 2016 was comprised of three directors: Ms. Brege (Chairperson), Dr. Oronsky and Ms. Phillips ... The following table shows for the fiscal year ended December 31, 2016, certain information with respect to the compensation of all non-employee directors of the Company: Peggy V. Phillips $62,500 Fees Earned or Paid in Cash, $70,692 Option Awards, $133,192 Total.
2017-07-10	Peggy V. Phillips, Director
2018-04-20	Peggy V. Phillips 64 Director ... Our Compensation Committee is composed of three directors: Ms. Phillips (Chairperson) and Drs. Kisner and Cano ... Our Nominating and Governance Committee is composed of three directors: Drs. Kisner (Chairperson) and Cano, and Mr. Ricciardi ... The following table shows for the fiscal year ended December 31, 2017, certain information with respect to the compensation of all non-employee directors of the Company: Peggy V. Phillips $62,500 $29,203 $91,703
2019-04-22	Our Board presently has eight members. There are three directors in the class whose term of office expires in 2019: Dennis A. Carson, M.D., Eddie Gray, and Laura Brege, each of whom is a nominee for director and currently a director of the Company. Dr. Carson, Mr. Gray and Ms. Brege were previously elected by the stockholders in 2016. If each nominee is elected at the Annual Meeting, each of these nominees will serve until the 2022 Annual Meeting and until his or her successor is elected and has qualified, or, if sooner, until the director's death, resignation or removal. We have a policy encouraging our directors' attendance at our annual meetings. There were six directors in attendance at our 2018 Annual Meeting. Directors are elected by a plurality of the votes of the holders of shares present in person or represented by proxy and entitled to vote on the election of directors. The three nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the nominees named below. Although the election of directors at the Annual Meeting is uncontested and directors are elected by a plurality of votes cast, and we therefore anticipate that each of the named nominees for director will be elected at the Annual Meeting, under our Corporate Governance Guidelines, any nominee for director is required to submit an offer of resignation for consideration by the Nominating and Corporate Governance Committee if such nominee for director (in an uncontested election) receives a greater number of "Withhold" votes than "For" votes. In such case, the Nominating and Corporate Governance Committee will then consider all of the relevant facts and circumstances and recommend to the Board the action to be taken with respect to such offer of resignation. For more information on this policy see the section entitled "Corporate Governance." If any nominee becomes unavailable for election as a result of an unexpected occurrence, your shares will be voted for the election of a substitute nominee proposed by our Board. Each person nominated for election has agreed to serve if elected. Our Board has no reason to believe that any nominee will be unable to serve. Our Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Governance Committee. The following table provides membership and meeting information for fiscal year 2018 for each of the Board committees: Name Audit Compensation Nominating Peggy V. Phillips X X * ... The following table shows for the fiscal year ended December 31, 2018, certain information with respect to the compensation of all non-employee directors of the Company: Name Fees Earned or Paid in Cash Option Awards Total Peggy V. Phillips $ 65,000 $ 156,767 $ 221,767
2020-04-17	Peggy V. Phillips Ms. Phillips has been a member of our Board since August 2006. Ms. Phillips served on the board of directors of several biopharmaceutical companies: PhaseRx, Inc. from 2016 to 2018, Tekmira Pharmaceuticals from 2014 to 2015, Portola Pharmaceuticals from 2006 to 2013, as well as the Naval Academy Foundation from 2003 to 2011. From 1996 until 2002, she served on the board of directors of Immunex Corporation, a biotechnology company, and, from 1999, she served as its Chief Operating Officer until the company was acquired by Amgen in 2002. During her career at Immunex, she held positions of increasing responsibility in research, development, manufacturing, sales and marketing. As Senior Vice President for Pharmaceutical Development and General Manager for Enbrel ® from 1994 until 1998, she was responsible for clinical development and regulatory affairs as well as the launch, sales and marketing of the product. Prior to joining Immunex, Ms. Phillips worked at Miles Laboratories. Ms. Phillips holds a B.S. and a M.S. in microbiology from the University of Idaho. The Board believes that Ms. Phillips provides significant experience in development and commercialization of biotechnology products. Her background and experience with larger, complex organizations provides significant operational and strategic insights in assessing the strategy of the Company and qualifies her to serve as a director.
2021-04-16	Peggy V. Phillips Ms. Phillips has been a member of our Board since August 2006. ... The Board believes that Ms. Phillips provides significant experience in development and commercialization of biotechnology products. ... The following table shows for the fiscal year ended December 31, 2020, certain information with respect to the cash compensation of all non-employee directors of the Company: ... Peggy V. Phillips Fees Earned or Paid in Cash $65,000, Option Awards $83,168, Total $148,168.
2022-04-14	Ms. Phillips has been a member of our Board since August 2006. Ms. Phillips served on the board of directors of several biopharmaceutical companies... We believe that Ms. Phillips provides significant experience in development and commercialization of biotechnology products and that here background and experience with larger, complex organizations provides significant operational and strategic insights in assessing the strategy of the Company and qualifies her to serve as a director.
2023-04-13	Peggy V. Phillips Ms. Phillips has been a member of our Board since August 2006. ... Our Board believes that Ms. Phillips provides significant experience in development and commercialization of biotechnology products. Our Board believes that Ms. Phillips’s background and experience with large, complex organizations provides significant operational and strategic insights in assessing the strategy of the Company and qualifies her to serve on our Board.
2024-04-11	Peggy V. Phillips Ms. Phillips has been a member of our Board since August 2006. ... Our Board believes that Ms. Phillips provides significant experience in development and commercialization of biotechnology products. Our Board believes that Ms. Phillipss background and experience with large, complex organizations provides significant operational and strategic insights in assessing the strategy of the Company and qualifies her to be nominated as a director.